NCT07117214View on ClinicalTrials.gov

A Phase I Study of [68Ga]Ga-DWJ155 in Patients With Breast and Lung Cancers

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 20, 2025

Primary Completion Date

January 26, 2027

Study Completion Date

January 26, 2027

Conditions
Breast NeoplasmsCarcinoma, Non-Small-Cell Lung
Interventions
DRUG

[68Ga]Ga-DWJ155

Radioligand imaging agent

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY